Articles with public access mandates - Scott LetendreLearn more
Not available anywhere: 10
Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS
A Winston, A Antinori, P Cinque, HS Fox, M Gisslen, TJ Henrich, ...
Aids 33, S107-S111, 2019
Mandates: US National Institutes of Health, National Institute for Health Research, UK
Penetration and effectiveness of antiretroviral therapy in the central nervous system
S Letendre, RJ Ellis, B Best, A Bhatt, J Marquie-Beck, S LeBlanc, S Rossi, ...
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly …, 2009
Mandates: US National Institutes of Health
Development and validation of a UHPLC–MS/MS assay for elvitegravir measurement in human plasma and cerebrospinal fluid
AJ Ocque, CE Hagler, J Lapham, GD Morse, S Letendre, Q Ma
Separation Science Plus 1 (5), 325-333, 2018
Mandates: US National Institutes of Health
The clinical utility of three frailty measures in identifying HIV-associated neurocognitive disorders
DJ Moore, N Sun-Suslow, AA Nichol, EW Paolillo, R Saloner, SL Letendre, ...
AIDS, 10.1097, 2022
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Brief Report: Sex Differences in the Association Between Cerebrovascular Function and Cognitive Health in People Living With HIV in Urban China
FC Chow, F Zhao, Y He, X Song, J Zhang, D Ao, Y Wu, B Hou, FA Sorond, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 92 (3), 217-222, 2023
Mandates: US National Institutes of Health
Risk factors for progression from prediabetes to diabetes among older persons with HIV
MC Masters, K Tassiopoulos, Y Bao, K Wu, SL Koletar, LH Rubin, J Yang, ...
AIDS, 10.1097, 2022
Mandates: US National Institutes of Health
Intrathecal production of anti-EBV viral capsid antigen IgG is associated with Neurocognition and tau pathology in people with HIV
M Trunfio, A Sacchi, D Vai, F Pittaluga, M Croce, R Cavallo, D Imperiale, ...
AIDS, 10.1097, 2022
Mandates: Government of Italy
Stimulating dissemination of research that addresses the social and contextual drivers of HIV prevention and treatment in the journal AIDS
J Schneider, R Coutinho, AM Hatcher, J Larmarange, S Letendre, ...
AIDS 37 (7), 1021, 2023
Mandates: US National Institutes of Health
Longitudinal Study of Cognitive Function in People with HIV and Toxoplasmic Encephalitis or Latent toxoplasma Infection
MM Diaz, JA Mccutchan, M Crescini, B Tang, D Franklin, SL Letendre, ...
AIDS, 10.1097, 2022
Mandates: US National Institutes of Health
Albert M. Anderson, William R. Tyor, 2, 3 Mark J. Mulligan
D Waldrop-Valverde, JL Lennox, SL Letendre
Clinical Infectious Diseases 67 (1), 137-40, 2018
Mandates: US National Institutes of Health
Available somewhere: 328
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
RK Heaton, DB Clifford, DR Franklin Jr, SP Woods, C Ake, F Vaida, ...
Neurology 75 (23), 2087-2096, 2010
Mandates: US National Institutes of Health
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
RK Heaton, DR Franklin, RJ Ellis, JA McCutchan, SL Letendre, S LeBlanc, ...
Journal of neurovirology 17, 3-16, 2011
Mandates: US National Institutes of Health
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
RJ Ellis, J Badiee, F Vaida, S Letendre, RK Heaton, D Clifford, AC Collier, ...
Aids 25 (14), 1747-1751, 2011
Mandates: US National Institutes of Health
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
CM Marra, Y Zhao, DB Clifford, S Letendre, S Evans, K Henry, RJ Ellis, ...
Aids 23 (11), 1359-1366, 2009
Mandates: US National Institutes of Health
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study
RK Heaton, DR Franklin Jr, R Deutsch, S Letendre, RJ Ellis, K Casaletto, ...
Clinical Infectious Diseases 60 (3), 473-480, 2015
Mandates: US National Institutes of Health
Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy
TH Burdo, MR Lentz, P Autissier, A Krishnan, E Halpern, S Letendre, ...
Journal of Infectious Diseases 204 (1), 154-163, 2011
Mandates: US National Institutes of Health
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
I Grant, DR Franklin Jr, R Deutsch, SP Woods, F Vaida, RJ Ellis, ...
Neurology 82 (23), 2055-2062, 2014
Mandates: US National Institutes of Health
Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life
AT Rodriguez-Penney, JE Iudicello, PK Riggs, K Doyle, RJ Ellis, ...
AIDS patient care and STDs 27 (1), 5-16, 2013
Mandates: US National Institutes of Health
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
LA Cysique, F Vaida, S Letendre, S Gibson, M Cherner, SP Woods, ...
Neurology 73 (5), 342-348, 2009
Mandates: US National Institutes of Health
Controversies in HIV-associated neurocognitive disorders
S Nightingale, A Winston, S Letendre, BD Michael, JC McArthur, S Khoo, ...
The Lancet Neurology 13 (11), 1139-1151, 2014
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Publication and funding information is determined automatically by a computer program